High-Risk Localized and Locally Advanced Prostate Cancer
Around 20%-30% of nonmetastatic prostate cancer patients have high-risk localized disease. The best treatment for high-risk localized disease is still unclear, and the reliability of the definition of "high-risk" may need to be validated first. Although recent advances in radiotherapy for...
Saved in:
Other Authors: | Izumi, Kouji (Editor) |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prostate Cancer
Published: (2023) -
Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options
Published: (2020) -
Multimodal Therapy of Upper Gastrointestinal Malignancies
Published: (2021) -
Controversies in the Local Management of Lung Cancer
by: John M. Varlotto
Published: (2018) -
Prospects from Diagnosis to Treatment in Cancer Using Magnetic Methods
Published: (2023)